Pfizer Inc. (PFE) Q2 2018 Earnings Results

Pfizer Beats on EPS, Stock Up 3.47%

Pfizer's earnings report shows a positive surprise in EPS, which likely contributed to the stock's increase of 3.47%. The company did not provide revenue figures or guidance, but management's optimistic tone suggests confidence in their future prospects. Investors may view the EPS beat as a sign of underlying strength in Pfizer's operations.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.81	N/A	+7.50%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a cautiously optimistic outlook, emphasizing their commitment to innovation. They highlighted the importance of their pipeline in driving future growth.

Management highlighted strong performance in key therapeutic areas.

They expressed confidence in ongoing product development.

The focus remains on maintaining operational efficiency.

Pfizer Beats on EPS, Stock Up 3.47%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Up 3.47%

Key numbers

Management commentary